Solid Biosciences (SLDB) Interest Expenses (2023 - 2025)

Solid Biosciences has reported Interest Expenses for 10 years, with the latest figure at $5.4 million in Q1 2026.

• Quarterly Interest Expenses rose 3779.29% year-over-year to $5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.4 million (up 3779.29% YoY) and the FY2025 annual result came in at $190.4 million, up 45.72% from the prior year.
• Interest Expenses grew to $5.4 million in Q1 2026 per SLDB's latest filing, from $4.4 million in the prior quarter.
• Over five years, Interest Expenses peaked at $163.6 million in Q4 2022 and troughed at $51000.0 in Q1 2022.
• A 5-year average of $10.9 million and a median of $140000.0 in 2025 frame the typical range for Interest Expenses.
• The sharpest annual moves came in 2023 and 2026: Interest Expenses sank 97.46% in 2023, then jumped 3779.29% in 2026.
• Over 5 years, Interest Expenses stood at $163.6 million in 2022, then tumbled by 97.46% to $4.2 million in 2023, then declined by 3.92% to $4.0 million in 2024, then advanced by 9.63% to $4.4 million in 2025, then rose by 23.88% to $5.4 million in 2026.
• According to Business Quant data, Interest Expenses over the past three periods registered $5.4 million, $4.4 million, and $1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.